Reed SD, Radeva JI, Glendenning GA, Saad F, Schulman KA. Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. J Urol. 2004 Apr;171(4):1537–42. doi: 10.1097/01.ju.0000116777.94426.60. PMID: 15017215.